Analyze Diet
Veterinary journal (London, England : 1997)2014; 201(3); 423-426; doi: 10.1016/j.tvjl.2014.05.014

Impact of tetrodotoxin application and lidocaine supplementation on equine jejunal smooth muscle contractility and activity of the enteric nervous system in vitro.

Abstract: By blocking the enteric nervous system (ENS) using tetrodotoxin (TTX), previous studies have documented the contractility-enhancing (CE) effects of lidocaine in equine intestinal smooth muscle (SM) at the level of SM cells and/or interstitial cells of Cajal (ICC). The present study examined the impact of ENS deactivation on CE lidocaine effects, and investigated the effects of lidocaine on ENS activity. TTX application did not affect the CE effects of lidocaine, indicating that these were not mediated by TTX-sensitive sodium channels. Application of TTX or ≥100 mg/L lidocaine reduced ENS activity. Although such concentrations of lidocaine exceed therapeutic blood concentrations, tissue concentrations may be higher with the potential to reduce ENS activity and impair intestinal motility in vivo. Improved understanding of underlying mechanisms is relevant for therapeutic use of lidocaine in horses with postoperative ileus.
Publication Date: 2014-05-15 PubMed ID: 24923755DOI: 10.1016/j.tvjl.2014.05.014Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article discusses the effects of two drugs, tetrodotoxin and lidocaine, on the contractility of intestinal muscles and the activity of the enteric nervous system in horses.

Objective of the Research

In the field of veterinary medicine, particularly equine health, a significant understanding of how drugs impact internal systems like intestinal muscles or the enteric nervous system (ENS) is crucial. The authors of this paper delve into the effects of tetrodotoxin (TTX) and lidocaine on both the smooth gut muscles (SM) and ENS in horses.

Previous Studies

  • The paper references prior studies which found that lidocaine had an enhancing effect on muscle contractility when the ENS was blocked using TTX.
  • These contractility-enhancing (CE) effects occurred at the level of SM cells and/or interstitial cells of Cajal (ICC).

Methodology and Findings

  • The research conducted aimed to further investigate this observed phenomenon.
  • The authors found that the application of TTX did not influence the CE effects of Lidocaine. This indicates that Lidocaine’s effects are not transmitted via TTX-sensitive sodium channels.
  • Furthermore, when TTX or a high dosage (≥100mg/L) of lidocaine was applied, it resulted in reduced ENS activity.

Implications of the Findings

  • Although the observed lidocaine concentration which led to reduced ENS activity was higher than therapeutic doses, the authors suggest that actual tissue concentrations could potentially be higher. This is cause for concern as it could lead to impaired intestinal motility in live horses.
  • This research thus provides avenues for further investigation into how lidocaine is applied in a therapeutic setting, especially for horses suffering from postoperative ileus, a condition of reduced intestinal motility.

Conclusion of the Research

Based on their findings, it can be concluded that TTX and lidocaine do have significant effects on equine intestinal muscle contractility and enteric nervous system activity. It further underscores the importance of understanding the underlying mechanisms involved before using lidocaine therapeutically for postoperative ileus in horses.

Cite This Article

APA
Tappenbeck K, Hoppe S, Geburek F, Feige K, Huber K. (2014). Impact of tetrodotoxin application and lidocaine supplementation on equine jejunal smooth muscle contractility and activity of the enteric nervous system in vitro. Vet J, 201(3), 423-426. https://doi.org/10.1016/j.tvjl.2014.05.014

Publication

ISSN: 1532-2971
NlmUniqueID: 9706281
Country: England
Language: English
Volume: 201
Issue: 3
Pages: 423-426
PII: S1090-0233(14)00211-1

Researcher Affiliations

Tappenbeck, K
  • Department of Physiology, University of Veterinary Medicine, Bischofsholer Damm 15, D-30173 Hannover, Germany.
Hoppe, S
  • Department of Physiology, University of Veterinary Medicine, Bischofsholer Damm 15, D-30173 Hannover, Germany.
Geburek, F
  • Clinic for Horses, University of Veterinary Medicine, Bünteweg 9, D-30559 Hannover, Germany.
Feige, K
  • Clinic for Horses, University of Veterinary Medicine, Bünteweg 9, D-30559 Hannover, Germany.
Huber, K
  • Department of Physiology, University of Veterinary Medicine, Bischofsholer Damm 15, D-30173 Hannover, Germany. Electronic address: korinna.huber@tiho-hannover.de.

MeSH Terms

  • Animals
  • Enteric Nervous System / drug effects
  • Enteric Nervous System / physiology
  • Gastrointestinal Motility / drug effects
  • Horses / physiology
  • Interstitial Cells of Cajal / drug effects
  • Jejunum / drug effects
  • Jejunum / physiology
  • Lidocaine / pharmacology
  • Muscle Contraction / drug effects
  • Muscle, Smooth / drug effects
  • Muscle, Smooth / physiology
  • Sodium Channel Blockers / pharmacology
  • Tetrodotoxin / pharmacology
  • Voltage-Gated Sodium Channel Blockers / pharmacology

Citations

This article has been cited 2 times.
  1. Ueno N. The Effect of Sodium Channel Blocker, Mexiletine, on Body Weight in Type 2 Diabetes Patients with Visceral Obesity. Clin Med Insights Endocrinol Diabetes 2019;12:1179551418825049.
    doi: 10.1177/1179551418825049pubmed: 30733634google scholar: lookup
  2. Beaussier M, Delbos A, Maurice-Szamburski A, Ecoffey C, Mercadal L. Perioperative Use of Intravenous Lidocaine. Drugs 2018 Aug;78(12):1229-1246.
    doi: 10.1007/s40265-018-0955-xpubmed: 30117019google scholar: lookup